What are the advantages of Mohs surgery for skin cancer?

Written in association with: Dr Cristina Bordea
Published: | Updated: 30/08/2023
Edited by: Laura Burgess

The goal of Mohs surgery is to remove skin cancer, whilst doing minimal damage to surrounding healthy tissue. It is especially useful for skin cancers that have a high risk of recurrence or that have recurred after previous treatment. The procedure is used on areas where you want to preserve as much healthy tissue as possible, such as around the eyes, ears, nose, mouth, hands, feet and genitals.

Here, leading plastic surgeon Dr Cristina Bordea explains the benefits of the surgical procedure.
 

What are the advantages of Mohs surgery?

Mohs micrographic surgery is considered the most effective technique for treating many basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs), the two most common types of skin cancer.

As Mohs surgery examines 100% of tumour margins at the time of surgery it spares healthy tissue that would normally be removed with conventional surgery and thus leaves the smallest wound possible. This can reduce the scarring in repairing the wound or reduce the complexity of reconstruction in certain parts of the body.

It is particularly useful in treating infiltrative basal cell carcinomas, where the edges of the tumour can be difficult to see such that conventional surgery risks incomplete removal. It is also useful in treating very large tumours and removing as little healthy skin as possible to minimise the size of the wound.

The cure rate with Mohs surgery, cited by most studies, is between 97% and 99.8% for primary basal-cell carcinoma and up to 95% for recurrent basal cell carcinoma. This compares to a cure rate of approximately 90% for a primary tumour removed by conventional surgery.
 

What other ways are basal cell carcinomas and squamous cell carcinomas treated?

Traditionally, operations for treating skin cancer surgically involve removal of the area affected by the skin cancer together with a suitable margin of healthy unaffected skin around and below the skin cancer, in order to try and ensure that the cancer has been completely removed.

Once removed, the skin is sent to a laboratory for examination by a pathologist to confirm whether the tumour has been completely removed. It usually takes between 1-2 weeks for the pathology report to become available. If the report shows that the skin cancer has not been fully removed a further procedure may be necessary.
 

Are there alternative treatments?

Radiotherapy may be an option for some patients. Radiation oncologists quote cure rates from 90 to 95% for BCCs less than 1 or 2 cm and 85 to 90% for BCCs larger than 1 or 2 cm.

Photodynamic therapy is a treatment that can be used for some skin cancers. It uses a drug, called a photosensitiser which is injected into the bloodstream and taken up by the cancer cells. A specific wavelength of light is then shone onto the area 24-72 hours later. When the photosensitisers are exposed to the specific wavelength of light they produce a form of oxygen that kills nearby cells.
 

How do I know if Mohs surgery is right for me?

Mohs surgery is regarded as the gold standard for treating many basal cell carcinomas and squamous cell carcinomas, including those in cosmetically and functionally important areas as mentioned before. Mohs is also recommended for basal cell carcinomas or squamous cell carcinomas that are large, aggressive or growing rapidly, that have indistinct edges, or have recurred after previous treatment.

Some surgeons are also successfully using Mohs surgery on certain cases of early melanoma; a type of melanoma called lentigo malignant melanoma. This type of melanoma stays close to the surface of the skin for a while. When treating melanoma, the surgeon uses a modified type of Mohs surgery called slow Mohs. It’s called slow because the patient must wait longer for the results. It’s not possible for the surgeon to look at the removed skin and know straight away whether it contains cancer cells. More time is needed.
 

Who shouldn’t have Mohs surgery?

Mohs surgery should really be reserved for the treatment of skin cancers in anatomic areas where tissue preservation is of utmost importance such as the face, hands, feet, nipples and genitals. Mohs surgery is not indicated on the trunk or extremities for uncomplicated, non-melanoma skin cancer of less than one centimetre in size.

 

Dr Cristina Bordea is an esteemed consultant plastic surgeon and dermatologist with over 25 years of experience. You can schedule an appointment with Dr Bordea on her Top Doctors profile.

By Dr Cristina Bordea
Dermatology

Dr Cristina Bordea is an experienced consultant plastic surgeon, based in Kettering. With over 25 years of experience, she specialises in skin cancer diagnosis and treatment including basal cell carcinoma, squamous cell carcinoma and malignant melanoma, diagnosis and treatment of benign skin lesions, skin checks and surveillance, mole assessment and removal, dermoscopy,  soft tissue lump removal, scar revision, split earlobe reconstruction and tattoo removal (not laser).

Dr Bordea currently runs a private practice at the Woodland Hospital in Kettering. She also works as a consultant in dermatology at Kettering General Hospital NHS Foundation Trust, where she is a member of the skin cancer multidisciplinary team. She graduated from the "Grigore T.Popa" University of Medicine and Pharmacy, in Romania. She then went on to receive her DPhil from the University of Oxford for research on skin cancers in renal transplant recipients, and her FRCSEd (Plast) from the Royal College of Surgeons.

She completed her surgical training at a number prestigious hospitals, including Queen Elizabeth Hospital in Birmingham, Guy’s and St Thomas’ Hospital in London and the Oxford University Hospitals NHS Trust in Oxford. She also undertook further specialist fellowships in skin oncology and hand surgery. She is on the GMC specialist register.

In addition to her medical work, Dr Bordea also has a strong academic background. When she is not treating patients, Dr Bordea carries out medical research, with a focus on skin cancer. She has presented her work at national and international meetings and published in peer-reviewed international journals. In 2016, Dr Bordea held the position of Visiting Scholar at the University of Tasmania in Australia, where she conducted research into stem cells.

She is a member of the British Association of Dermatologists, the Royal College of Surgeons of Edinburgh, the Royal College of Physicians and the British Society of Cosmetic Dermatology.

View Profile

Overall assessment of their patients


  • Related procedures
  • Medicine body aesthetics
    Laser
    Dark circles
    Lip augmentation
    Hidrolipoctasia cavitation
    Laser tattoo removal
    Laser scar therapy
    Laser Lifting
    Alopecia
    Hair transplant
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.